Skip to content

Efficacité de l’hydrodissection dans la prise en charge de la tendinopathie calcanéenne : essai clinique randomisé.

Efficacité de l’hydrodissection dans la prise en charge de la tendinopathie calcanéenne : essai clinique randomisé.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202607794865575
Enrollment
40
Registered
2026-07-17
Start date
2026-07-16
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases Orthopaedics

Interventions

hysdrodissection

Sponsors

Abourazzak Fatima Ezzahra
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Age = 18 years. Patients with fusiform mid-portion Achilles tendinopathy lasting for more than 3 months. Failure of = 3 months of conservative treatment (eccentric exercises, NSAIDs, shockwave therapy). Pain visual analog scale (VAS) score = 4/10. Signed informed consent.

Exclusion criteria

Exclusion criteria: Irreversible calcific tendinosis, insertional tendinopathy, and large intrasubstance tendon tears. Complete or partial Achilles tendon ruptures. Rheumatic disease. Patients who underwent recent corticosteroid injection or surgery (< 3 months). Pregnant or breastfeeding women. Local or systemic infection.

Design outcomes

Primary

MeasureTime frame
VISA-A (Victorian Institute of Sport Assessment–Achilles)

Secondary

MeasureTime frame
The Visual Analog Scale (VAS) for pain assessment. Ultrasound assessment of neovascularization and tendon thickness. Evaluation of analgesic consumption (paracetamol).

Countries

Morocco

Contacts

Public ContactChaimae Laghrissi

Rheumatology Resident at Tangier University Hospital Center

chaimae.laghrissi@usmba.ac.ma+212664423101

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 10, 2026